AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2016
Jul 26, 2016
30608_dirs_2016-07-26_b396fdca-6f94-478c-ae25-1e1e5f68a27b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SYNTA PHARMACEUTICALS CORP (MDGL)
CIK: 0001157601
Period of Report: 2016-07-22
Reporting Person: CRAVES FRED B (Director, 10% Owner)
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Regulatory Filings
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26